Gtaplex 1 X Liquid is a Health Canada–registered human drug (DIN 02233621) held by Bio Active Canada Ltd., containing Rosmarinus Officinalis. Health Canada lists its status as Cancelled Post Market (status date 28 Sep 2007). Nexara Health has matched 8 registrations of Rosmarinus Officinalis across 1 other regulated market.
Health Canada registration
| DIN | 02233621 |
|---|---|
| Brand name | Gtaplex |
| Active ingredient | Rosmarinus Officinalis |
| Strength | 1 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Bio Active Canada Ltd. |
| Status | Cancelled Post Market — 28 Sep 2007 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Rosmarinus Officinalis registered in other markets
8 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Rosmarinus Officinalis | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Rosmarinus Officinalis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Gtaplex (DIN 02233621) marketed in Canada?
No. Health Canada lists DIN 02233621 as Cancelled Post Market as of 28 Sep 2007.
Who holds the Canadian licence for this product?
Bio Active Canada Ltd. is the company of record in the Health Canada Drug Product Database.
Is Rosmarinus Officinalis registered outside Canada?
Yes — Nexara Health has matched 8 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233621, status date 2007-09-28; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233621, status date 2007-09-28; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02233621, status date 2007-09-28; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.